CD4 and myeloid sarcoma: Compared with the healthy control group, the FOXP3 mRNA level in MS patients was decreased, and further detection showed that the proportion of CD4+CD25+FOXP3+ Tregs in the total peripheral blood mononuclear cells (PBMC) of the patients was decreased.